Laurent Greillier

Centre National de la Recherche Scientifique

Also affiliated with Inserm, Aix-Marseille Université, Institut Gustave Roussy, Assistance Publique Hôpitaux de Marseille, Hôpital Nord

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743”.

First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743

Annals of Oncology(2022)10.1016/j.annonc.2022.01.074

N/A

5.7DataRank · unranked

265 citations

Arnaud Scherpereel, Robin Cornelissen, Youssef Oulkhouir, Laurent Greillier, Kaplan Ma +15 more

1224P Evaluation of safety and feasibility of adjuvant chemotherapy in elderly patients with primary non-small cell lung cancer

Annals of Oncology(2024)10.1016/j.annonc.2024.08.1283

N/A

0DataRank · unranked

0 citations

Y. Vincent, Faustine Enoch, Vanessa Pauly, A-L. Couderc, Pascale Tomasini +6 more